Clinical Trials Browser

Completed × Brain Neoplasms × cabozantinib × Clear all

NCT03967522 2025-08-08

CABRAMET

Phase 2 Completed

CNSGenitourinary

Brain Neoplasms, Carcinoma, Renal Cell

NCT02260531 2021-05-20

Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases

Phase 2 Completed

36 enrolled 19 charts

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms